Patient P-02675

Synthetic patientMETA-24 · Day 171 · 65–74 · M · baseline S20Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Declining

Discontinuation risk

27%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S20

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability+12
Nutritional resilience-11
Toxicity+5
Inflammatory activity+4

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

46 min

stable · +0.5 vs previous 14 d

Sleep duration

Wearable

5.9 h

stable · +0.0 vs previous 14 d

Energy level

Daily log

6.7/10

stable · +0.1 vs previous 14 d

Steps

Wearable

4,613

stable · -91 vs previous 14 d

GI burden

Companion

22.2/100

stable · +0.4 vs previous 14 d

Adherence

Companion

94.3 %

stable · -2.9 vs previous 14 d

Sleep quality

Wearable

32.1/100

worsening · -2.6 vs previous 14 d

Glucose, CGM daily mean

CGM

125 mg/dL

stable · -2.3 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 91 from the failing basin, 11 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -5.6 next day on high-intake days · n 19

Would not help

Keep caffeine low
GI +6.3 next day on high-intake days · n 21
Keep alcohol low
GI +5.9 next day on high-intake days · n 20

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Caffeine
+6.3detractor · 95%
Alcohol
+5.9detractor · 95%
Protein
-5.6supporter · 95%
Dietary fat load
+2.5no signal · 39%
Simple carbohydrates
-1.3no signal · 22%
Histamine load
+1.1no signal · 16%
Ultra-processed food
+0.5no signal · 15%
Insoluble fibre
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
Autonomic recovery ↓20
- WearableShort sleep window
Mucosal barrier integrity ↓10
- WearableSleep 5.9 h, below personal baseline

DNA

Fictional pharmacogenomic panel

CYP2D6 Poor metabolizer
Higher exposure at standard dose
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 3 · butyrate capacity 55/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 59 ms
Sleep: 6.6 h
Steps: 4,032
Resting HR: 63 bpm

Daily log: GI score 22, nutritional resilience 62, adherence 94.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02555	47%	S01	AD-05	no change	79
P-02277	44%	S05	AD-05	improved	92
P-02282	51%	S01	BR-03	no change	88
P-02013	48%	S14	BR-03	no change	94
P-02193	39%	S11	CR-01	improved	87
P-02354	33%	S01	CR-01	improved	78
P-02081	47%	S20	DT-01	no change	88
P-02565	47%	S09	DT-01	no change	79
P-02337	43%	S18	DT-01	no change	100
P-02249	37%	S09	DT-01	improved	100
P-02462	33%	S12	DT-01	improved	65
P-02491	32%	S09	DT-01	no change	65